The Europe medical scheduling software market is expected to grow from US$ 113.33 million in 2022 to US$ 237.38 million by 2028. It is estimated to grow at a CAGR of 13.1% from 2022 to 2028.
Increased engagement with all stakeholders (providers, patients, and others), leading to reduced overall expenses. Improved knowledge and understanding among patients of their health, well-being, and healthcare choices leading to enhanced care and reduced levels of illness. This improved knowledge can also improve care after discharge, hospital visits, reduced readmissions, and secondary consults. By engaging and collaborating with patients in decision-making, health providers can make more suitable decisions regarding a patient’s health. Increased competitive advantage as more hospitals compete for patients based on both qualities of care and cost. Better quality of life for patients leads to an increase in the satisfaction of both doctor and patient.
In recent years the patient-centric approach has been predominant in the healthcare industry. Technological innovations and software development are crucial to this healthcare industry revolution. These technological developments support medical and administrative services that dramatically enhance and ease healthcare processes, communications, and workflow. Patient-centric healthcare raises patient satisfaction levels, which creates benefits for healthcare providers and practices. Thus, the rising adoption of a patient-centric approach by healthcare providers driving the growth of the medical scheduling software market.
The market for medical scheduling software in Germany is anticipated to witness significant growth due to the reforms undertaken by the government to reduce the waiting time. Long waiting lines are inefficient and therefore an undesirable form of rationing since they decrease utility gains from consultation and treatment. Some of the measures undertaken to reduce the waiting time in medical practices include, higher spending, waiting-times target schemes and incentive mechanisms, which reward higher levels of activity. In 2015, policymakers began a reform intended towards tackling the issue of rising waiting time in the outpatient sector. The reform is part of a law aimed at improving medical services in general (Versorgungsstärkungsgesetz). Part of the requirements is the creation of service stations for appointments (Terminservicestellen). The implementation of reform would ensure faster appointment, hence leading to decreased waiting time. The implementation of such reforms is anticipated to offer significant growth opportunity for the medical scheduling software market in Germany during the coming years.
Based on software, the Europe medical scheduling software market is segmented into web-based software and installed software. The web-based software held a larger Europe medical scheduling software market share in 2022.
Based on end user, the Europe medical scheduling software market is segmented into hospitals, clinics, and other end users. The hospitals segment held the largest Europe medical scheduling software market share in 2022.
Based on country, the Europe medical scheduling software market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe medical scheduling software market share in 2022.
Biosoftworld Ltd, SuperSaaS BV, TerminApp GmbH, and WellSky are some of the leading companies operating in the Europe medical scheduling software market in the region.
Reasons to Buy
Rising Adoption of Patient-Centric Approach by Healthcare Providers Fuels Europe Medical Scheduling Software Market
A patient-centric approach is an idea in healthcare systems that can establish a partnership among patients & their families and healthcare practitioners to align decisions with patients’ needs, preferences, and wants. It also includes the delivery of specific education and support patients require to make certain decisions and participate in their care.Increased engagement with all stakeholders (providers, patients, and others), leading to reduced overall expenses. Improved knowledge and understanding among patients of their health, well-being, and healthcare choices leading to enhanced care and reduced levels of illness. This improved knowledge can also improve care after discharge, hospital visits, reduced readmissions, and secondary consults. By engaging and collaborating with patients in decision-making, health providers can make more suitable decisions regarding a patient’s health. Increased competitive advantage as more hospitals compete for patients based on both qualities of care and cost. Better quality of life for patients leads to an increase in the satisfaction of both doctor and patient.
In recent years the patient-centric approach has been predominant in the healthcare industry. Technological innovations and software development are crucial to this healthcare industry revolution. These technological developments support medical and administrative services that dramatically enhance and ease healthcare processes, communications, and workflow. Patient-centric healthcare raises patient satisfaction levels, which creates benefits for healthcare providers and practices. Thus, the rising adoption of a patient-centric approach by healthcare providers driving the growth of the medical scheduling software market.
Europe Medical Scheduling Software Market Overview
Europe region includes France, Germany, Italy, Spain, United Kingdom, and the Rest of Europe. The region is expected to witness a steady growth rate of 13.1% from 2022 to 2028. The European medical scheduling software market is expected to witness significant growth during the forecast period, due to factors such as adoption of reforms to reduce waiting times, growth of the private healthcare sector as well as increase in the use of information technology in healthcare industry.The market for medical scheduling software in Germany is anticipated to witness significant growth due to the reforms undertaken by the government to reduce the waiting time. Long waiting lines are inefficient and therefore an undesirable form of rationing since they decrease utility gains from consultation and treatment. Some of the measures undertaken to reduce the waiting time in medical practices include, higher spending, waiting-times target schemes and incentive mechanisms, which reward higher levels of activity. In 2015, policymakers began a reform intended towards tackling the issue of rising waiting time in the outpatient sector. The reform is part of a law aimed at improving medical services in general (Versorgungsstärkungsgesetz). Part of the requirements is the creation of service stations for appointments (Terminservicestellen). The implementation of reform would ensure faster appointment, hence leading to decreased waiting time. The implementation of such reforms is anticipated to offer significant growth opportunity for the medical scheduling software market in Germany during the coming years.
Europe Medical Scheduling Software Market Revenue and Forecast to 2028 (US$ Million)
Europe Medical Scheduling Software Market Segmentation
The Europe medical scheduling software market is segmented into software, end user, and country.Based on software, the Europe medical scheduling software market is segmented into web-based software and installed software. The web-based software held a larger Europe medical scheduling software market share in 2022.
Based on end user, the Europe medical scheduling software market is segmented into hospitals, clinics, and other end users. The hospitals segment held the largest Europe medical scheduling software market share in 2022.
Based on country, the Europe medical scheduling software market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe medical scheduling software market share in 2022.
Biosoftworld Ltd, SuperSaaS BV, TerminApp GmbH, and WellSky are some of the leading companies operating in the Europe medical scheduling software market in the region.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical scheduling software market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe medical scheduling software market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the medical scheduling software market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Medical Scheduling Software Market - Market Landscape
5. Europe Medical Scheduling Software Market - Key Market Dynamics
6. Europe Medical Scheduling Software Market- Europe Analysis
7. Europe Medical Scheduling Software Market - Revenue and Forecast to 2028 - by Software
8. Europe Medical Scheduling Software Market Analysis and Forecasts to 2028 - by End User
9. Europe Medical Scheduling Software Market - Revenue and Forecast to 2028 -Country Analysis
10. Global Medical Scheduling Software Market - Industry Landscape
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned
- Biosoftworld Ltd
- SuperSaaS BV
- TerminApp GmbH
- WellSky
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 86 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value in 2022 | 113.33 Million |
| Forecasted Market Value by 2028 | 237.38 Million |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 4 |
